Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
mAb2
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021
mAb8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/24/2021
GX-19
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/24/2021
ZF2001
Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021
Tubocurarine
Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021
Mezerein
Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021
Ginkgolide M
Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021
Neferine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Tetrandrine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
1-{3-[2-Hydroxy-3-(4-methylpiperidino)propoxy]phenoxy}-3-(4-methylpiperidino)-2-propanol
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Hernandezine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Cepharanthine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Plerixafor
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Floxuridine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Darapladib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Litronesib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Flumatinib
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Kasugamycin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
Spectinomycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Pentamidine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021